Skip to content

Effect of remimazolam or ciprofol combined with oxycodone on the quality of recovery after thoracoscopic surgery in elderly patients

Effect of remimazolam or ciprofol combined with oxycodone on the quality of recovery after thoracoscopic surgery in elderly patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097280
Enrollment
Unknown
Registered
2025-02-17
Start date
2025-02-24
Completion date
Unknown
Last updated
2025-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

OR Group:Remimazolam and oxycodone are used during anesthesia
OC Group:Ciprofol and oxycodone are used during anesthesia
NC Group:Ciprofol is used during anesthesia
NR Group:Remimazolam is used during anesthesia

Sponsors

The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: The subjects of this study were elderly patients aged 60-80 years, ASA ?-?, with body mass index of 16-30 kg/m2, undergoing thoracoscopic surgery under general anesthesia, with operation time <=2 hours, and undergoing postoperative PCIA.

Exclusion criteria

Exclusion criteria: Exclusion criteria: patients with a history of chronic pain or opioid abuse before surgery, drug and/or alcohol abuse within the past 3 months, cognitive impairment or language impairment with poor communication, schizophrenia and severe depression, myasthenia gravis, severe organ dysfunction, and drug allergy. Have participated in clinical research of other drugs or medical devices in the past 3 months;

Design outcomes

Primary

MeasureTime frame
Qor-15 score at 24 h postoperatively;

Secondary

MeasureTime frame
Qor-15 score at 48 h postoperatively;Qor-15 score at 72 h postoperatively;Resting pain score at 2 h postoperatively;Resting pain score at 6 h postoperatively;Resting pain score at 12 h postoperatively;Resting pain score at 24 h postoperatively;Resting pain score at 48 h postoperatively;Pain score during activity at 12 h after surgery;Pain score during activity at 24 h after surgery;Pain score during activity at 48 h after surgery;Agitation-sedation (RASS) score after awakening in PACU;Agitation-sedation (RASS) score at 4 hours after surgery;Agitation-sedation (RASS) score at 12 hours after surgery;Agitation-sedation (RASS) score at 24 hours after surgery;Agitation-sedation (RASS) score at 48 hours after surgery;Intraoperative dosage of remifentanil;Intraoperative dosage of remimazolam;Intraoperative dosage of Ciprofol;The use of vasoactive drugs during surgery;Time required for extubation after surgery;The rate of salvage analgesia in PACU;The length of stay in PACU;The incidence of delirium and agitation in PACU;Fluid intake during surgery;Blood loss during surgery;Urine output during surgery;The occurrence of adverse reactions within 48 hours after surgery;

Countries

China

Contacts

Public ContactYing Wang

The First Affiliated Hospital of Zhengzhou University

gxy5582@126.com+86 137 3380 3893

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026